GWS
BIO icon

Glassman Wealth Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Glassman Wealth Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$16.1K – 405
2023
Q4 		$16.1K Buy
50
+28
+127% +$8.78K ﹤0.01% 744
2023
Q3 		$7.89K Sell
22
-16
-42% -$6.17K ﹤0.01% 922
2023
Q2 		$14.4K Buy
38
+14
+58% +$5.7K ﹤0.01% 709
2023
Q1 		$11.5K Buy
24
+6
+33% +$2.81K ﹤0.01% 781
2022
Q4 		$7.57K Buy
18
+1
+6% +$404 ﹤0.01% 904
2022
Q3 		$7K Buy
17
+6
+55% +$2.99K ﹤0.01% 894
2022
Q2 		$5K Sell
11
-3
-21% -$1.56K ﹤0.01% 984
2022
Q1 		$8K Buy
14
+3
+27% +$1.81K ﹤0.01% 884
2021
Q4 		$8K Buy
11
+9
+450% +$6.74K ﹤0.01% 853
2021
Q3 		$1K Hold
2
– – ﹤0.01% 1285
2021
Q2 		$1K Buy
2
+1
+100% +$609 ﹤0.01% 1237
2021
Q1 		$1K Buy
+1
New +$592 ﹤0.01% 1198
2020
Q1 		– Sell
-10
Closed -$4K – 1148
2019
Q4 		$4K Hold
10
– – ﹤0.01% 604
2019
Q3 		$3K Sell
10
-2
-17% -$652 ﹤0.01% 601
2019
Q2 		$4K Sell
12
-2
-14% -$599 ﹤0.01% 571
2019
Q1 		$4K Sell
14
-2
-13% -$540 ﹤0.01% 567
2018
Q4 		$4K Sell
16
-2
-11% -$537 ﹤0.01% 447
2018
Q3 		$6K Sell
18
-3
-14% -$931 ﹤0.01% 449
2018
Q2 		$6K Sell
21
-3
-13% -$828 ﹤0.01% 416
2018
Q1 		$6K Buy
+24
New +$6.11K ﹤0.01% 395

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Glassman Wealth Services's BIO Position: Q1 2024 in Review

Glassman Wealth Services sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 50 shares — an estimated $16.1K sold.

Glassman Wealth Services first reported a position in BIO in Q1 2018 and held it in 20 quarters. The position peaked at $16.1K in Q4 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Glassman Wealth Services reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 50 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $16.1K.
  • Glassman Wealth Services first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 20 quarters.
  • Glassman Wealth Services's Bio-Rad Laboratories Class A position peaked at $16.1K in Q4 2023.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.